Middle East & Africa Over-the-Counter (OTC) Drugs Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Over-the-counter(OTC) medicine is also known as OTC or nonprescription medicine. All these terms refer to that medicine because you can buy without a prescription. They are safe and effective when you follow the directions on the label and as directed by your healthcare professional. These drugs are used for relieving aches, pains, and itches. Some drugs prevent or cure diseases, and others help manage recurring problems, like a migraine. OTC drugs help consumers in self-diagnosing, self-treating, and self-managing acute problems, like a headache, arthritis pain, sprains, and other minor joint and muscle problems.

The Middle East & Africa Over-the-Counter (OTC) Drugs Market Segments Size & Growth:

The Middle East & Africa Over-the-Counter (OTC) drugs market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include Product Innovation, High Penetration in emerging markets, Immense cost savings, Favorable regulatory framework, and Inclination of pharmaceutical companies to switch from Rx to OTC drugs. However, Probability of substance abuse, lack of awareness among the rural regions and Incorrect self-diagnosis are thereby hampering the market growth.

The Middle East & Africa Over-the-Counter (OTC) Drugs Market Segments Share:

The Middle East & Africa Over-the-Counter (OTC) drugs market is categorised into Product Category which comprises of Cough, Cold and flu products, Analgesics, Dermatology products, Gastrointestinal products, Vitamins, mineral and supplements (VMS), Weight loss/Dietary products, Ophthalmic Products, Sleep Aids, and Others. Among these, cough, cold and flu products hold the most significant share in the market. By Geography, Brazil is projected to dominate the market with the most significant share and the growth in the South America economies is mainly attributed because of huge profit margins and growth prospects.

The Middle East & Africa Over-the-Counter (OTC) Drugs Market Trends:

• GlaxoSmithKline plc (GSK) and NanoBio Corporation announced an exclusive licensing agreement for the over-the-counter (OTC) use of NB-001, a novel, patented compound representing the next advance in the treatment of cold sores.
• Cilag GmbH International announced definitive agreements to acquire the over-the-counter (OTC) brands of J B Chemicals & Pharmaceuticals Limited for the equivalent of approximately U.S. $260 million in cash.

The Middle East & Africa Over-the-Counter (OTC) Drugs Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players, such as

• Johnson and Johnson
• Bayer
• Boehringer Ingelheim
• GSK
• Novartis